Source: Drug Delivery Business

Health Catalyst Capital Management: Glooko raises $30M Series D

Diabetes and obesity management tech developer Glooko announced today that it raised $30 million in a Series D financing round. Palo Alto, Calif.-based Glooko, which develops remote patient monitoring and chronic care management products including data management technologies for insulin delivery devices, said in a news release that proceeds from the financing will be used [...]The post Glooko raises $30M Series D appeared first on Drug Delivery Business.

Read full article »

Top Competitors or Alternatives

Looks like nobody has added any competitors for Health Catalyst Capital Management yet.

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
CEO Avatar


Update CEO

CEO Approval Rating

- -/100

Read more